Certified by Founder Lodge
Enara Bio
United Kingdom - Oxford, Oxfordshire
START UP
1 Disclosed Funding Rounds $32,500,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 04 ,2024 | Series B | $32,500,000 |
SV Health Investors
Pfizer
RA Capital Management, L.P.
Samsara BioCapital
M Ventures(Netherlands)
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
